StockNews.com Begins Coverage on Galmed Pharmaceuticals

GLMD Stock  USD 2.76  0.06  2.13%   
About 61% of Galmed Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Galmed Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Galmed Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Galmed Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals in a research report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical companys stock. Galmed Pharmaceuticals Stock Up 290.2 percent GLMD stock opened at 15.10 on Friday. Galmed Pharmaceuticals has a 12-month low of 2.73 and a 12-month

Read at thelincolnianonline.com
news
  

Galmed Pharmaceuticals Fundamental Analysis

We analyze Galmed Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galmed Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galmed Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Galmed Pharmaceuticals is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Galmed Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Galmed Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Galmed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Galmed Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Galmed Pharmaceuticals Related Equities

PDSBPDS Biotechnology   9.21   
0%
87.0%
ADAPAdaptimmune Therapeutics   5.17   
0%
49.0%
MREOMereo BioPharma   2.09   
0%
19.0%
ADVMAdverum Biotechnologies   1.15   
0%
10.0%
KODKodiak Sciences   0.74   
0%
7.0%
AKBAAkebia Ther   0.44   
0%
4.0%
ABEOAbeona Therapeutics   0.37   
0%
3.0%
ACHLAchilles Therapeutics   0.88   
8.0%
0%
AFMDAffimed NV   2.00   
18.0%
0%
FBIOFortress Biotech   2.79   
26.0%
0%
FBIOPFortress Biotech   3.40   
32.0%
0%
MBIOMustang Bio   4.09   
38.0%
0%
LPTXLeap Therapeutics   8.77   
83.0%
0%
APTOAptose Biosciences   10.53   
100.0%
0%

Complementary Tools for Galmed Stock analysis

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device